Fmoc-N-Methyl-L-isoleucine

Fmoc-N-Methyl-L-isoleucine is an Fmoc-protected, N-methylated L-isoleucine derivative that retains the L-configured stereogenic center at the amino acid alpha carbon while converting the amine into an N-methylamide-equivalent protected functionality for peptide chemistry. The structure combines a fluorenylmethoxycarbonyl (Fmoc) carbamate on the nitrogen with an isoleucine side chain bearing a branched aliphatic framework, providing hydrophobic character and conformational bias typical of isoleucine-based building blocks. The N-methyl substitution reduces the availability of the amide nitrogen for hydrogen bonding during coupling and subsequent transformations, which can influence peptide secondary structure and protease recognition patterns in peptidomimetic designs. The Fmoc group enables standard base-labile deprotection to generate a reactive amino functionality for iterative chain assembly, while the N-methyl motif supports downstream derivatization and stable amide formation under peptide coupling conditions.

1. Peptide Synthesis

Fmoc-N-Methyl-L-isoleucine supports automated and manual solid-phase peptide synthesis where Fmoc deprotection and subsequent amide bond formation are central to stepwise chain construction. The protected amino acid derivative presents an Fmoc-carbamate that can be removed under base conditions to reveal the N-methylated amino nucleophile, enabling coupling strategies that maintain the L-stereocenter. The isoleucine side chain contributes hydrophobic side-chain packing, and the N-methyl substitution can modulate backbone hydrogen bonding and local conformational preferences in the growing peptide. Incorporation of this chiral, N-methylated building block can be applied to generate peptide analogs for structure-activity relationship studies and to prepare libraries of N-methylated residues for synthetic peptide chemistry.

2. Peptidomimetics And SAR

Fmoc-N-Methyl-L-isoleucine is used in peptidomimetic construction and structure-activity relationship studies where N-methylation is a common strategy to tune conformational stability and proteolytic resistance. The N-methyl group alters amide NH availability, which can reduce intermolecular hydrogen bonding and affect folding propensity when the residue is embedded in a peptide scaffold. The L-isoleucine stereochemistry and branched aliphatic side chain provide stereodefined, hydrophobic interactions that can be leveraged to probe binding site preferences in SAR workflows. Fmoc-N-Methyl-L-isoleucine can be employed as a residue-level modification tool to systematically vary backbone features while keeping the side-chain identity consistent across analog series.

3. Unnatural Amino Acid Incorporation

Fmoc-N-Methyl-L-isoleucine functions as a chiral amino acid intermediate for unnatural amino acid incorporation into peptide and peptidomimetic frameworks. The compound's N-methylated amine character enables incorporation of a residue that differs from standard proteinogenic isoleucine at the backbone nitrogen, allowing researchers to introduce controlled deviations in peptide hydrogen-bonding patterns. The Fmoc protection strategy supports compatibility with peptide coupling chemistries used to assemble sequences containing noncanonical residues while preserving stereochemical integrity at the alpha carbon. Downstream synthetic utility includes preparing N-methylated analogs for biochemical research intermediate generation, molecular recognition studies, and scaffold diversification in synthetic organic chemistry.

4. Chemical Biology Labeling

Fmoc-N-Methyl-L-isoleucine can be applied in chemical biology workflows that require incorporation of N-methylated amino acid residues into functional peptide probes. The Fmoc-protected form enables site-specific placement during peptide synthesis, after which the resulting N-methyl amide linkage provides a stable backbone element for subsequent conjugation chemistry. The isoleucine side chain supports hydrophobic interactions that may improve probe behavior in membrane-associated or ligand-binding contexts during assay development. The resulting N-methylated peptide constructs can be further functionalized through orthogonal side-chain or terminal modification strategies, supporting biomolecule labeling and probe generation for target engagement studies.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-N-Methyl-L-isoleucine is suitable for pharmaceutical manufacturing-oriented peptide intermediate preparation where controlled residue incorporation is required for consistent downstream processing. The Fmoc group provides a well-defined, base-labile protection handle that aligns with established peptide synthesis manufacturing practices for generating protected intermediates and final peptide materials. The N-methylated backbone motif can be used to produce peptide drug candidates or peptide-like intermediates with altered stability profiles relevant to process development and formulation screening, without changing the stereochemical identity of the alpha carbon. The compound's defined structure supports reproducible synthetic routes for fine chemical synthesis and specialty chemical production, including the preparation of N-methylated peptide fragments used in larger assembly steps.

6. Process Chemistry and Fine Chemical Synthesis

Fmoc-N-Methyl-L-isoleucine can be employed as a chiral building block in process chemistry for the preparation of N-methylated amino acid derivatives and peptide coupling-ready intermediates. The combination of an Fmoc-protected nitrogen and an L-configured amino acid framework supports scalable synthesis planning where protection and deprotection steps are integrated into controlled manufacturing sequences. The N-methyl substitution can influence purification behavior and coupling kinetics in peptide assembly, which may be leveraged to design robust synthetic workflows for specialty chemical production. Downstream utility includes generating protected amino acid derivatives for iterative chain construction, producing peptidomimetic fragments for medicinal chemistry programs, and supplying standardized intermediates for analytical method development related to amino acid and peptide characterization.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die